About Human Rabies Immunoglobulin Vaccines
We are leading exporter and manufacturer of Human Rabies Immunoglobulin Vaccines.
Uses
Human Papillomavirus Vaccine Type11 L1Protien is used in the treatment of pre cancerous anal lesions, pre cancerous genital lesions (cervical, vulvar and vaginal), cervical cancer, anal cancer and genital warts (skin bumps on or around the genital or anal area)
How it works
Human Papillomavirus Vaccine Type11 L1Protien is a vaccine. It helps to develop immunity by initiating a mild infection. This type of infection does not cause illness, but it does stimulate the bodys immune system to produce antibodies to protect against any future infections.
Common side effects
Headache, Nausea, Rash, Joint pain, Vomiting, Fever, Urticaria, Abdominal pain, Itching, Injection site reaction, Diarrhoea, Muscle pain.
Tag:
Human Rabies Immunoglobulin Vaccines, Quadrivalent Vaccines/ Pentavalent Vaccin Vaccine exporter, Human Rabies Immunoglobulin Vaccines, Quadrivalent Vaccines/ Pentavalent Vaccin Vaccine manufacturer
Human Rabies Immunoglobulin Vaccines, Quadrivalent Vaccines/ Pentavalent Vaccin Vaccine supplier, Human Rabies Immunoglobulin Vaccines, Quadrivalent Vaccines/ Pentavalent Vaccin Vaccine manufacturer in India,
Human Rabies Immunoglobulin Vaccines, Quadrivalent Vaccines/ Pentavalent Vaccin Vaccine exporter in India.
Rapid Passive Immunization Against RabiesHuman Rabies Immunoglobulin is crucial for immediate passive protection after potential rabies exposure. This injection works by neutralizing the rabies virus, which is essential when there is a risk of infection before the bodys own immune response can be triggered by vaccination.
Strict Quality and Safety StandardsEach vial is formulated with highly purified immunoglobulin G (IgG) at over 95% purity and is free from contaminants. The product is supplied in sterile, clear, or slightly opalescent liquid form, ensuring safety and efficacy during use, as well as meeting hospital and clinical standards.
Indications and AdministrationPrescribed for both adults and children, human rabies immunoglobulin should be administered only by trained healthcare professionals. Dosage is typically 20 IU/kg, as recommended by the physician, and it must not be used in individuals with hypersensitivity to human immunoglobulins.
FAQs of Human Rabies Immunoglobulin Vaccines:
Q: How is Human Rabies Immunoglobulin administered?
A: Human Rabies Immunoglobulin is given by intramuscular injection under the supervision of a medical professional, usually at a hospital or clinical setting. It should never be self-administered.
Q: What is the main purpose of Human Rabies Immunoglobulin?
A: This immunoglobulin is used for post-exposure prophylaxis and immediate protection against rabies by providing passive immunity until the patient develops their own immune response following vaccination.
Q: When should Human Rabies Immunoglobulin be given?
A: It must be administered as soon as possible after a suspected or confirmed rabies exposure, ideally in combination with rabies vaccine, following the guidance of a healthcare provider.
Q: What dosage of Human Rabies Immunoglobulin is typically recommended?
A: The recommended dosage is 20 IU per kilogram of body weight, but the exact amount may vary as prescribed by the physician based on individual circumstances.
Q: Where should this product be stored and how long is it viable?
A: Store the vials at 2C to 8C and protect from light. Do not freeze. The product has a shelf life of 2 years when stored under recommended conditions.
Q: What precautions should be taken before using Human Rabies Immunoglobulin?
A: This product should not be used in individuals with a known hypersensitivity to human immunoglobulins. It must be administered by qualified healthcare personnel, and patient monitoring is advised during and after injection.